Anzeige
Mehr »
Login
Freitag, 18.10.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
5 Millionen Unzen und steigend: NexGold Mining's unerschlossene Goldstraße
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 923566 | ISIN: US7693971001 | Ticker-Symbol:
NASDAQ
17.10.24
21:47 Uhr
4,730 US-Dollar
+0,060
+1,28 %
1-Jahres-Chart
RIVERVIEW BANCORP INC Chart 1 Jahr
5-Tage-Chart
RIVERVIEW BANCORP INC 5-Tage-Chart
GlobeNewswire (Europe)
112 Leser
Artikel bewerten:
(0)

Riverview Bancorp Inc: Nicole Sherman Named President and Chief Executive Officer of Riverview Bancorp

VANCOUVER, Wash., June 21, 2024 (GLOBE NEWSWIRE) -- Riverview Bancorp, Inc. (Nasdaq GSM: RVSB) ("Riverview" or the "Company") today announced that Nicole Sherman has been named President and Chief Executive Officer of Riverview Bancorp and Riverview Bank, effective July 01, 2024. She also will join the Boards of Directors of both the Company and the Bank.

"With over 25 years of proven experience growing community banking organizations, including the past 20 years in the Pacific Northwest, Nicole Sherman is the right person to lead Riverview into the future," said Gerald L. Nies, Chairman of the Board. "Nicole has an established record of building a high-performance banking culture, and we are excited about the expertise, energy and professionalism that she brings to Riverview."

Ms. Sherman is well-known as a catalyst for financial innovation and regarded as a brilliant change agent and unwavering positive force in the industry. She is a "leader builder" throughout organizations and does so by her actions, work ethic, high standards and dedicated coaching and mentoring of others. As a visionary and an architect of momentum, Ms. Sherman leverages past accomplishments to fuel future innovation. Her "live on purpose, lead with intention" philosophy and dedication inspires others to see their greatness and bring that level of engagement every single day. This past March, Ms. Sherman served as the Greater Chamber of Commerce's keynote speaker at the Inspire Her Conference.

Ms. Sherman brings over 25 years of experience at the Chief, Executive and Senior VP levels with organizations such as Columbia Bank, Utah First, Numerica Credit Union, AmericanWest Bank, and Zions Bank. Her expertise ranges from Retail and Digital Banking, Commercial and Business Banking to Wealth Management including Private Banking and Financial Services, as well as Corporate Marketing and Communications, DEIBA and Community Impact and Philanthropy.

Additionally, Ms. Sherman has led through 10 successful mergers and acquisitions throughout her career. Known for her paramount presentation style, she is a Keynote and Transformational Speaker. Since 2003, Ms. Sherman has been a top-rated faculty member at Pacific Coast Banking School (PCBS) at the University of Washington, Foster School of Business and was named 2023 Instructor of the Year.

"I am thrilled to join the team at Riverview," said Ms. Sherman. "Riverview is an organization with an unwavering dedication to serving its clients and its communities, and I look forward to leading our efforts in support of that commitment. I am confident that our deeply dedicated team is capable of growing Riverview as we capitalize on opportunities taking place within the banking industry."

Over the past nine months, Dan Cox has served as the bank's acting CEO/President. Dan will now focus full-time on his role as EVP, Chief Operating Officer. "We are grateful for all that Dan has done for Riverview through this transition. He has demonstrated immense leadership while guiding our organization. We continue to rely on his leadership and significant contribution to Riverview's mission and strategic vision," said Nies.

Riverview's CEO selection committee engaged J. Scott Petty, Managing Partner of Chartwell Partner's Financial Services Practice to conduct an extensive national search. "Scott and his team did a fantastic job guiding our committee through the selection process," said Stacey Graham, Riverview Board of Director member and chair of the selection committee.

About Riverview

Riverview Bancorp, Inc. (www.riverviewbank.com) is headquartered in Vancouver, Washington - just north of Portland, Oregon, on the I-5 corridor. With assets of $1.52 billion at March 31, 2024, it is the parent company of the 101-year-old Riverview Bank, as well as Riverview Trust Company. The Bank offers true community banking services, focusing on providing the highest quality service and financial products to commercial and retail clients through 17 branches, including 13 in the Portland-Vancouver area, and 3 lending centers. For the past 10 years, Riverview has been named Best Bank by the readers of The Vancouver Business Journal and The Columbian.

This press release contains statements that the Company believes are "forward-looking statements." These statements relate to the Company's financial condition, results of operations, plans, objectives, future performance or business. You should not place undue reliance on these statements, as they are subject to risks and uncertainties. When considering these forward-looking statements, you should keep in mind these risks and uncertainties, as well as any cautionary statements the Company may make. Moreover, you should treat these statements as speaking only as of the date they are made and based only on information then actually known to the Company.

Contacts:Dan Cox and David Lam
Riverview Bancorp, Inc. 360-693-6650

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/9666fcb4-469e-4e84-a471-65cd76a6d279


Sherman bio picture - gld-FINAL
© 2024 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.